FilingSEC EDGAR8-K
Allogene Therapeutics CFO Geoffrey Parker to Retire
· SEC accepted
StageRetirement
Filing content
Allogene Therapeutics' CFO Geoffrey Parker will retire effective November 6, 2026.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…